SEKISUI Diagnostics

SEKISUI Diagnostics is part of the SEKISUI Chemical Co. Ltd. family and is a sister company to SEKISUI Medical. Backed by the resources of its global parent, SEKISUI Diagnostics remains focused on contributing to the realization of healthy and enriched lifestyles for all people.

With more than 550 employees worldwide, SEKISUI Diagnostics is headquartered in Burlington, Massachusetts. It supports research and development and manufacturing facilities on two different continents where long-tenured sales and service staff concentrate on building strong partnerships with customers across the globe.

SEKISUI Diagnostics strives to improve patient outcomes by doing what it has always done—focus on innovating and developing highly accurate diagnostic tests, reagents, and systems.

The company’s clinical diagnostic experience includes the development of the first homogeneous test for LDL, and it has become a leading provider of rapid tests in the U.S. and of high-throughput coagulation analyzer systems in Japan.

In addition, SEKISUI Diagnostics is a leading manufacturer of enzymes and specialty biochemicals for the global healthcare market. It supplies premium materials for biotherapeutic manufacturing, pharmaceutical production, clinical chemistry reagent development, and point-of-care/biosensor device creation. It also offers expertise in process development, fermentation, and purification.

SEKISUI Diagnostics products include:

• Clinical chemistry reagents
• Coagulation reagents
• Rapid tests
• Point-of-care testing immunoassay systems
• Enzymes and specialty biochemicals
• Pre-analytic systems